Skip to main content
. 2017 Jul 4;117(4):503–512. doi: 10.1038/bjc.2017.197

Table 2. Multivariate analysis of clinical prognostic factors for the development of prostate cancer recurrence and any-cause death.

  Any recurrence
Any-cause death
  HR (95% CI) P HR (95% CI) P
All prostate cancer cases
cT stage 1.33 (0.77–2.3) 0.3 0.63 (0.26–1.56) 0.32
PSA 1.07 (0.77–1.48) 0.7 0.86 (0.51–1.46) 0.58
Primary Gleason⩾4 1.72 (1.01–2.93) 0.048 2.2 (0.93–5.2) 0.07
Total TOPK 1.73 (1.02–2.92) 0.04 1.65 (0.72–3.8) 0.24

Abbreviations: CI=confidence interval; HR=hazard ratio; PSA=prostate specific antigen.